ID   BEAS-2B/c-myc
AC   CVCL_LJ64
SY   BEAS 2B-c-myc; 2B-myc
DR   Wikidata; Q54795944
RX   Patent=US5443954;
RX   PubMed=1712250;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9869.
CC   Transfected with: HGNC; 7553; MYC.
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0168 ! BEAS-2B
SX   Male
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 05-10-23; Version: 9
//
RX   Patent=US5443954;
RA   Reddel R.R., Yang K., Rhim J.S., Brash D.E., Su R.T., Lechner J.F.,
RA   Gerwin B.I., Harris C.C., Amstad P.;
RT   "Immortalized non-tumorigenic human bronchial epithelial cell lines.";
RL   Patent number US5443954, 22-Aug-1995.
//
RX   PubMed=1712250;
RA   Pfeifer A.M.A., Jones R.T., Bowden P.E., Mann D., Spillare E.,
RA   Klein-Szanto A.J.P., Trump B.F., Harris C.C.;
RT   "Human bronchial epithelial cells transformed by the c-raf-1 and c-myc
RT   protooncogenes induce multidifferentiated carcinomas in nude mice: a
RT   model for lung carcinogenesis.";
RL   Cancer Res. 51:3793-3801(1991).
//